IDEAS home Printed from https://ideas.repec.org/h/spr/sprchp/978-0-387-30107-5_25.html
   My bibliography  Save this book chapter

Data Monitoring of a Placebo-Controlled Trial of Daclizumab in Acute Graft-Versus-Host Disease

In: Data Monitoring in Clinical Trials

Author

Listed:
  • David Zahrieh

    (Dana-Farber Cancer Institute, Department of Biostatistics and Computational Biology)

  • Stephanie J. Lee

    (Dana-Farber Cancer Institute, Department of Medical Oncology)

  • David Harrington

    (Dana-Farber Cancer Institute, Department of Medical Oncology
    Harvard School of Public Health, Department of Biostatistics)

Abstract

This trial was undertaken to test the hypothesis that two-drug initial therapy for acute graft-versus-host disease (GVHD) would produce better control of GVHD and less exposure to corticosteroids than the standard treatment of corticosteroids alone. All participants had undergone allogeneic hematopoietic stem cell transplantation (HSCT) and developed acute GVHD. Subjects were randomized to treatment with corticosteroids plus placebo or corticosteroids plus daclizumab. The trial was continued past its first interim analysis (~30%; evaluable subjects) but was stopped after the second interim analysis (~50%; evaluable subjects) when the two-drug arm was associated with worse overall survival.

Suggested Citation

  • David Zahrieh & Stephanie J. Lee & David Harrington, 2006. "Data Monitoring of a Placebo-Controlled Trial of Daclizumab in Acute Graft-Versus-Host Disease," Springer Books, in: David L. DeMets & Curt D. Furberg & Lawrence M. Friedman (ed.), Data Monitoring in Clinical Trials, chapter 0, pages 269-277, Springer.
    • Handle: RePEc:spr:sprchp:978-0-387-30107-5_25
    DOI: 10.1007/0-387-30107-0_25
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a
    for a similarly titled item that would be available.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprchp:978-0-387-30107-5_25. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.